Properties
What is it?
Composition: 1ml spray contains: Nasal spray: Active substance: Oxymetazoline hydrochloride 0.5mg; Excipients: Microcrystalline cellulose and sodium carmellose (Avicel RC-591) 30mg, sodium phosphate 0.975mg, sodium dihydrogen phosphate monohydrate 5.525mg, disodium edetate dihydrate 0.3mg, macrogol-1450 50mg, povidone-K29-32 30mg, benzyl alcohol 2.5mg, lemon flavor 1.5mg, benzalkonium chloride 17% solution 1.471mg, glycerol 5mg, purified water q.s. up to 1ml. Nasal spray (chamomile): Active substance: Oxymetazoline hydrochloride 0.5mg; Excipients: Microcrystalline cellulose and sodium carmellose (Avicel RC-591) 30mg, sodium phosphate 0.975mg, sodium dihydrogen phosphate monohydrate 5.525mg, disodium edetate dihydrate 0.3mg, macrogol-1450 50mg, povidone-K29-32 30mg, benzyl alcohol 2.5mg, chamomile flavor 0.2mg, benzalkonium chloride 17% solution 1.471mg, glycerol 5mg, purified water q.s. up to 1ml. Description: Nasal spray: White or almost white gel-like suspension with a characteristic citrus scent. Nasal spray (chamomile): White or almost white gel-like suspension. Indications: Symptomatic therapy of allergic and/or infectious-inflammatory rhinitis (cold), sinusitis, Eustachian tube inflammation, hay fever. Otitis (reduction of swelling of the nasopharyngeal mucosa). Facilitation of secretion drainage in diseases of the nasal paranasal sinuses. Preparation of the patient before diagnostic manipulations in the nasal cavity. Contraindications: Hypersensitivity to sympathomimetic agents or any component of the preparation; use of monoamine oxidase inhibitors within 2 weeks before and 2 weeks after discontinuation of the preparation; angle-closure glaucoma; surgical interventions on the dura mater of the brain (in history); post-transsphenoidal hypophysectomy; atrophic (dry) rhinitis; acute cardiovascular diseases or acute left ventricular failure; severe uncontrolled arterial hypertension; children under 6 years of age. Use during pregnancy and lactation: The safety of the preparation in pregnant women and during lactation has not been established, therefore, the use of the preparation in pregnant women and nursing mothers should only be done on the recommendation of a doctor, when the expected benefit of the preparation for the mother outweighs the potential risk to the fetus or infant. Caution should be exercised when signs of arterial hypertension or reduced placental blood flow appear. Frequent or prolonged use of large doses of the preparation may cause a reduction in placental blood flow. Method of administration and dosage: Intranasally. The spray bottle must be shaken vigorously before each use. After the first use of the spray, it must be "calibrated" by pressing the spray head several times. Adults and children from 10 years of age - 1-2 sprays in each nasal cavity at 12-hour intervals. Children aged 6-10 years - one spray in each nasal cavity at 12-hour intervals. Overdose is not recommended. If symptoms worsen or no improvement occurs within 3 days, consult a doctor. Do not use for more than 7 days at the recommended doses without consulting a doctor. With frequent and prolonged use of the preparation, the feeling of nasal congestion may reappear or worsen. If these symptoms appear, discontinue treatment and consult a doctor. Storage conditions: Store at a temperature not exceeding 25C, out of reach of children.